Hemogenyx Pharmaceuticals Plc (HEMO) ORD GBP0.01
20.90p
(6.48%)
- Add to watchlist
- Create an alert
- This stock can be held in a
20.90p
(6.48%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
20.90p
(6.48%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
335.00p
343.40p
420.00p
£12.03 million
322.50p
310.00p
0.88p
n/a
2.50p (0.78%) Previous:
2.50p
17,825
n/a
500
Performance
Not available for this stock.
Fundamental data
| Year ending: | 31/12/2023 | 31/12/2022 |
|---|---|---|
| Revenue (£m) | n/a | n/a |
| Profit before tax (£m) | (6.70) | (3.99) |
| Adjusted EPS (p): | (240.00) | (200.00) |
| P/E ratio | n/a | n/a |
| PEG | n/a | n/a |
| EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: British pound
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
There are no documents available for this stock.
-
Hemogenyx shares boosted by partner investment
2 October 2024 11:56
-
Hermogenyx shares soar on new partnership with Prevail Partners
18 September 2023 13:00
-
Ultrafast CAR-T Manufacturing
19 December 2024 07:00
Annual & interim reports
Annual & interim reports are not available for this stock.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.